We provide you with 20 years of free, institutional-grade data for GH stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GH. Explore the full financial landscape of GH stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-30 | 1576280 | GH | 10-Q | Url |
| 2025-04-30 | 1576280 | GH | 10-Q | Url |
| 2025-02-20 | 1576280 | GH | 10-K | Url |
| 2024-11-06 | 1576280 | GH | 10-Q | Url |
| 2024-08-07 | 1576280 | GH | 10-Q | Url |
| 2024-05-09 | 1576280 | GH | 10-Q | Url |
| 2024-02-22 | 1576280 | GH | 10-K | Url |
| 2023-11-06 | 1576280 | GH | 10-Q | Url |
| 2023-08-03 | 1576280 | GH | 10-Q | Url |
| 2023-05-09 | 1576280 | GH | 10-Q | Url |
| 2023-02-23 | 1576280 | GH | 10-K | Url |
| 2022-11-03 | 1576280 | GH | 10-Q | Url |
| 2022-08-04 | 1576280 | GH | 10-Q | Url |
| 2022-05-05 | 1576280 | GH | 10-Q | Url |
| 2022-02-24 | 1576280 | GH | 10-K | Url |
| 2021-11-04 | 1576280 | GH | 10-Q | Url |
| 2021-08-05 | 1576280 | GH | 10-Q | Url |
| 2021-05-06 | 1576280 | GH | 10-Q | Url |
| 2021-02-25 | 1576280 | GH | 10-K | Url |
| 2020-11-05 | 1576280 | GH | 10-Q | Url |
| 2020-08-06 | 1576280 | GH | 10-Q | Url |
| 2020-05-07 | 1576280 | GH | 10-Q | Url |
| 2020-03-02 | 1576280 | GH | 10-K | Url |
| 2019-11-07 | 1576280 | GH | 10-Q | Url |
| 2019-08-07 | 1576280 | GH | 10-Q | Url |
| 2019-05-20 | 1576280 | GH | S-1 | Url |
| 2019-05-10 | 1576280 | GH | 10-Q | Url |
| 2019-03-19 | 1576280 | GH | 10-K | Url |
| 2018-11-19 | 1576280 | GH | 10-Q | Url |
| 2018-09-06 | 1576280 | GH | S-1 | Url |
Guardant Health(NASDAQ:GH) 
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico resear...
Website: https://guardanthealth.com/
Founded: 2013
IPO Price: $19 (Oct 04, 2018)
Full Time Employees: 1,728 (Dec 2022)
CEO / Co-Founder: Helmy Eltoukhy
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about GH stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.